SYSCO Sees Waning Appetites
692841
Food distributor reports sales slowdown, but again finishes year with record earnings.
234574
With growth in the meal assembly industry slowing, shop owners are trying to find new ways to bring ready-to-cook meals to the masses.
486820
The chain named after its desserts isn't as sweet as it used to be.
348955
The stock looks reasonably valued but some core businesses are struggling to grow.
739848
The Coca-Cola Company is lowering its long-term earning and sales targets. In a statement today (11 November), the company added that continued weak performance in certain key markets was expected in 2005 as operational issues are addressed.
335482
This retailer's still trying to loosen up.
487980
Organic was expected to be the next big food trend after Wal-Mart Stores Inc. and others threw their weight behind the products, but many executives are saying that overall, consumers are not yet clamoring for such fare.
661056
The retailer narrows its focus, but its work isn't done.
96833
Weight Watchers has seen some lean times, so to speak. The company&#39;s decades-old regimen of daily exercise, point-counting and monthly meetings hasn&#39;t been able to compete very well
485238
TROUBLE IS brewing in the aisles of Scotlandâs supermarkets. Products and produce once easy to hand are either on distant shelves or have simply disappeared altogether.
268925
The British-Swedish drug company has a great quarter, but the future looks dimmer.
79566
The world&#39;s largest soft drink maker, Coca Cola, has lowered its sales targets. The news, coming from the company&#39;s new CEO, Neville Isdell, is the latest gloomy forecast from the beverage giant.
661012
The consumer products conglomerate warns of lowers sales and profits.
367565
The cereal giant wants to limit its marketing of less-than-nutritious fare to children.
559757
The company needs to focus on its core brand rather than launching new products.
767118
The packaging firm's P/E looks reasonable, but free cash flow has dried up.
266043
The end of diet drug litigation may be in sight, but growth hasn't recovered yet.